Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Michel Allé | M | 74 |
Université Libre de Bruxelles
| 27 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Robert Kiss | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline.
Université Libre de Bruxelles
| 15 anni |
Yvan de Launoit | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | 12 anni |
Tanguy Cornet | M | - |
Université Libre de Bruxelles
| 5 anni |
Jean-Luc Samuel Francois Girardet | M | 57 |
Université de Montpellier
| 8 anni |
Piotr Tyranowski | M | - |
Université Libre de Bruxelles
| 4 anni |
Ugo Falcinelli | M | - |
Université Libre de Bruxelles
| 4 anni |
Alexey Viktorovich Lapikov | M | 48 |
Université de Montpellier
| 4 anni |
Tuan Van Nguyen | M | 54 |
Université Libre de Bruxelles
| 2 anni |
Stéphanie Vanden Broecke | F | - |
Université Libre de Bruxelles
| 3 anni |
Herjan Coelingh Bennink | M | - |
Université Libre de Bruxelles
| 8 anni |
Aminata Kaké | F | 47 |
Université Libre de Bruxelles
| 4 anni |
Nourredine Chinek | M | - |
Université Libre de Bruxelles
| 4 anni |
Frederic Halkin | M | - |
Université Libre de Bruxelles
| 1 anni |
Emmanuel Lacroix | M | - |
Université Libre de Bruxelles
| 4 anni |
Muriel de Lathouwer | F | 51 |
Université Libre de Bruxelles
| 4 anni |
Huong Giang Thi Luong | F | 57 |
Université Libre de Bruxelles
| 2 anni |
Benoît Taymans | M | - |
Université Libre de Bruxelles
| 4 anni |
Daniel Grossmann | M | 53 |
Université Libre de Bruxelles
| 5 anni |
Ayuporn Karnasuta | F | - |
Université Libre de Bruxelles
| 2 anni |
Alice Guilhon Lanfranchi | M | 57 |
Université de Montpellier
| 3 anni |
Gonzalo Tradacete Gallart | M | - |
Université Libre de Bruxelles
| 5 anni |
Ann J. Barbier | M | 59 |
Université Libre de Bruxelles
| 3 anni |
Bernd Karl-Friedrich Starrock | M | - |
Université de Montpellier
| 2 anni |
Bo I. Nilsson | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Steven D. Weitman | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Marc Hellemans | M | 51 |
Université Libre de Bruxelles
| 4 anni |
Alain Parthoens | M | 64 |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Kristel Verleyen | F | 53 |
Université Libre de Bruxelles
| 3 anni |
Amelie Coens | F | - |
Université Libre de Bruxelles
| 4 anni |
Dimitri Dimitriou | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Matthias de Raeymaeker | M | 49 |
Université Libre de Bruxelles
| 2 anni |
Antoine Duchateau | M | 70 |
Université Libre de Bruxelles
| 1 anni |
Keith Bragman | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Frédéric Zoller | M | - |
Université Libre de Bruxelles
| 4 anni |
Christiane Verhaegen | F | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | 5 anni |
Didier Georges | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Sven Arne Andréasson | M | 72 |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Sandrine Evrard | F | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Mathieu Francois Pierre Pasture | M | - |
Université Libre de Bruxelles
| 1 anni |
Sandrine Gautier | M | - |
Université de Montpellier
| 3 anni |
Abderrezak Kamel | M | - |
Université de Montpellier
| 1 anni |
Etienne van de Kerckhove | M | 60 |
Université Libre de Bruxelles
| 1 anni |
Frank van Vynckt | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Eric van Quaquebeke | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | 9 anni |
Marie Wintrebert-Fouquet | M | - |
Université de Montpellier
| 3 anni |
Didier Malherbe | M | - |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Belgio | 40 | 85.11% |
Francia | 7 | 14.89% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Francis Darro
- Contatti personali